Neuroscience

Jason Karlawish of the Perelman School of Medicine notes the benefits and risks of experimental Alzheimer’s drug lecanemab.

Daniel Yoshor of the Perelman School of Medicine says that Elon Musk’s Neuralink implant has impressive hardware but does not represent a dramatic advance in restoring or enhancing brain function.

Jason Karlawish of the Perelman School of Medicine says that the new data on experimental Alzheimer’s drug lecanemab show reason for both optimism and caution.

Dennis Kolson of the Perelman School of Medicine says that long-COVID patients uniformly appreciate the chance to talk with a physician who understands their symptoms.

Minhong Ma of the Perelman School of Medicine says that a Japanese study on food odors offers new insights into metabolic adaptation.

A study by Casey Halpern of the Perelman School of Medicine and colleagues found that electric shocks to the brain took away the cravings of two patients with binge eating disorder.

Nancy Bonini of the School of Arts & Sciences is lauded for her work studying Parkinson’s and other brain diseases by probing fruit fly genes.

A pilot study led by Casey Halpern of the Perelman School of Medicine finds that deep brain stimulation can curb the urge to overeat.

Mihir Kakara of the Perelman School of Medicine says that political debate formats do a disservice to candidates and viewers with disabilities, especially since language difficulties don’t necessarily signify cognitive impairment.